BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 16611209)

  • 1. Making the most of spontaneous adverse drug reaction reporting.
    Waller PC
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):320-3. PubMed ID: 16611209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.
    Blenkinsopp A; Wilkie P; Wang M; Routledge PA
    Br J Clin Pharmacol; 2007 Feb; 63(2):148-56. PubMed ID: 17274788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data mining for signals in spontaneous reporting databases: proceed with caution.
    Stephenson WP; Hauben M
    Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):359-65. PubMed ID: 17019675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How do pharmaceutical companies handle consumer adverse drug reaction reports? An overview based on a survey of French drug safety managers and officers.
    Fleuranceau-Morel P
    Pharmacoepidemiol Drug Saf; 2002; 11(1):37-44. PubMed ID: 11998550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study to build a database on seven anti-hypertensive drugs.
    Fujita T; Miura Y; Mayama T
    Pharmacoepidemiol Drug Saf; 2005 Jan; 14(1):41-6. PubMed ID: 15534857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of US poison centers in adverse drug reactions monitoring.
    Chyka PA
    Vet Hum Toxicol; 1999 Dec; 41(6):400-2. PubMed ID: 10592954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reporting of adverse drug reactions: predictors of under-reporting in Malaysia.
    Aziz Z; Siang TC; Badarudin NS
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):223-8. PubMed ID: 16947117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The application of knowledge discovery in databases to post-marketing drug safety: example of the WHO database.
    Bate A; Lindquist M; Edwards IR
    Fundam Clin Pharmacol; 2008 Apr; 22(2):127-40. PubMed ID: 18248442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneously reported fatal suspected adverse drug reactions: a 10-year survey from Sweden.
    Wester K; Jönsson A; Spigset O; Hägg S
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):173-80. PubMed ID: 16739241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of spontaneous adverse drug reaction (ADR) reports using supplementary information.
    Ghosh P; Dewanji A
    Stat Med; 2011 Jul; 30(16):2040-55. PubMed ID: 21544847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving global monitoring of vaccine safety: a quantitative analysis of adverse event reports in the WHO Adverse Reactions Database.
    Letourneau M; Wells G; Walop W; Duclos P
    Vaccine; 2008 Feb; 26(9):1185-94. PubMed ID: 18243428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a mail-out continuing education article to teach health professionals about drug-induced disease.
    Goldman SA
    J Clin Pharmacol; 1999 Nov; 39(11):1126-35. PubMed ID: 10579142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adverse drug reactions definitions and terminology].
    Rabinovitz H; Berkowitch M; Golik A; Shani S
    Harefuah; 2001 Dec; 140(12):1181-6, 1228. PubMed ID: 11789305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suspected adverse drug reactions in the Hungarian veterinary practice between 1982 and 1992.
    Bernáth S; Szászfai M; Kulcsár G; Halász M
    Acta Vet Hung; 1996; 44(4):451-6. PubMed ID: 9141281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Building a structured monitoring and evaluating system of postmarketing drug use in Shanghai.
    Du W; Levine M; Wang L; Zhang Y; Yi C; Wang H; Wang X; Xie H; Xu J; Jin H; Wang T; Huang G; Wu Y
    Can J Clin Pharmacol; 2007; 14(1):e40-4. PubMed ID: 17237524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paediatric adverse drug reaction reporting: understanding and future directions.
    Carleton BC; Smith MA; Gelin MN; Heathcote SC
    Can J Clin Pharmacol; 2007; 14(1):e45-57. PubMed ID: 17297195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reporting odds ratio and its advantages over the proportional reporting ratio.
    Rothman KJ; Lanes S; Sacks ST
    Pharmacoepidemiol Drug Saf; 2004 Aug; 13(8):519-23. PubMed ID: 15317031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unreported adverse drug reactions determined by screening physician orders for diphenhydramine.
    Fraterrigo CC; Estep JM; Palmer MA
    Hosp Pharm; 1981 Aug; 16(8):421-3, 426. PubMed ID: 10252375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors that influence spontaneous reporting of adverse drug reactions: a model centralized in the medical professional.
    Herdeiro MT; Polonia J; Gestal-Otero JJ; Figueiras A
    J Eval Clin Pract; 2004 Nov; 10(4):483-9. PubMed ID: 15482410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
    Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.